The company’s coalition advocates for the adoption of bioactives in the food and health industry.

The company has partnered with Luiten Foods to bring its cell-cultured Wagyu Beef to more than 25 European countries by 2025 with sustainability and climate as main motivations.

Renaissance BioScience, a global bioengineering company, has received new patent allowances and grants for its non-GMO acrylamide-reducing yeast (ARY) from regulatory authorities in China, Russia, India, Australia and Vietnam. These five new ARY patent grants and allowances join previously issued patents from the U.S., Japan, Indonesia, Chile and Colombia, with patents pending in multiple additional markets.

With a mandatory compliance date of January 1, 2022, USDA’s Agricultural Marketing Service (AMS) rule, “National Bioengineered Food Disclosure Standard (NFBDS),” requires “food manufacturers, importers and other entities that label foods for retail sale to disclose information about bioengineered (BE) food and BE food ingredients.